RDNT RadNet Inc.

RadNet to Make its Second Acquisition in Houston, Texas

RadNet to Make its Second Acquisition in Houston, Texas

LOS ANGELES, April 10, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services, today announces that it has signed a definitive agreement to purchase the assets of six imaging centers in the greater Houston, Texas metropolitan area. This acquisition, which is anticipated to be completed before the end of the second quarter of 2024, is RadNet’s second announced transaction in Houston, and upon closing, will bring the number of RadNet centers in this geography to 13. The previously announced acquisition of seven imaging centers from Houston Medical Imaging, LLC was completed on April 1st, 2024.

The six multimodality centers to be acquired offer a broad range of imaging services, including MRI, CT, mammography, ultrasound and x-ray, and currently operate under the American Health Imaging brand. Shortly after the completion of the acquisition, we intend to transition the branding of these centers to Houston Medical Imaging. RadNet anticipates that the acquired centers will add over 100,000 procedures and $15 million of revenue on an annual basis.

RadNet’s President and Chief Executive Officer, Howard Berger, MD explained, “We are excited to announce our second transaction in Houston, where RadNet can provide the patients and referring physicians of the greater Houston area increased access to high-quality, cost-effective outpatient diagnostic imaging services. Houston encompasses about 7.3 million people, making it the fourth most populous city and the second fastest growing metropolitan area in the United States. Houston presents an exciting opportunity for further growth, including de novo build-outs and potential health system partnerships, and we plan to introduce our AI and digital health solutions to the patient and referring communities in the near future.”

The asset acquisition is subject to customary closing conditions.

About RadNet, Inc.

RadNet, Inc., is the leading national provider of freestanding, fixed-site diagnostic imaging services and related information technology solutions (including artificial intelligence) in the United States based on the number of locations and annual imaging revenue. RadNet has a network of 366 owned and/or operated outpatient imaging centers. RadNet's markets include California, Maryland, Delaware, New Jersey, New York, Florida and Arizona. Together with affiliated radiologists, including full-time and per diem employees and technologists, RadNet has approximately 9,700 employees. For more information, visit

Forward Looking Statements

This press release contains certain statements that constitute "forward-looking statements" within the meaning of federal securities laws, including statements regarding the effects of the proposed transaction. These statements are based on the assumptions and beliefs of RadNet, Inc. management in light of the information currently available to it. Such statements are indicated by words or phrases such as "accelerate," "create," "committed," "confident," "continue," "deliver," "driving," "expect," "future," "guidance," "positioned," "strategy," "target," "synergies," "trends," and "will." Various uncertainties and other factors could cause actual results to differ materially from those contained in the forward-looking statements. These include the specific risk factors identified in "Risk Factors" in RadNet, Inc.’s annual report on Form 10-K for the last fiscal year and any subsequent filings, as well as the following:

the expected timing and likelihood of completion of the proposed transaction, including the timing, receipt and terms and conditions of any required governmental and regulatory clearance of the proposed transaction; the occurrence of any event, change or other circumstances that could give rise to the termination of the acquisition agreement; the inability to consummate the proposed transaction due to the failure to satisfy other conditions to complete the proposed transaction; the ability to identify and recognize the anticipated benefits of the proposed transaction, including anticipated revenue and procedural volumes; and the ability of RadNet, Inc. to successfully integrate the business and related operations; risks related to the potential impact of general economic, political and market factors on the companies or the proposed transaction. The ability of RadNet, Inc. to achieve the goals for the proposed transaction may also be affected by its ability to manage the factors identified above.

The forward-looking statements by RadNet, Inc. included in this press release speak only as of the date the statements were made. RadNet, Inc. does not assume any obligation to update the information contained herein unless required by applicable law. Please refer to the reports and filings of RadNet, Inc. with the Securities and Exchange Commission for a further discussion of the risks and uncertainties that affect it and its business.

Mark Stolper

Executive Vice President and Chief Financial Officer

RadNet, Inc.

310-445-2800



EN
10/04/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on RadNet Inc.

 PRESS RELEASE

RadNet Reports Second Quarter Financial Results with Record Quarterly ...

RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA¹ and Revises Upwards 2025 Financial Guidance Ranges Total Company Revenue increased 8.4% to a quarterly record of $498.2 million in the second quarter of 2025 from $459.7 million in the second quarter of 2024; Revenue from the Digital Health reportable segment (inclusive of intersegment revenue) increased 30.9% to a quarterly record of $20.7 million in the second quarter of 2025 from $15.8 million in the second quarter of 2024Total Company Adjusted EBITDA(1) was a quarterly record of $81.2 mill...

 PRESS RELEASE

DeepHealth, a RadNet Subsidiary, Receives FDA Clearance for Remote Sca...

DeepHealth, a RadNet Subsidiary, Receives FDA Clearance for Remote Scanning Solution, TechLive™ TechLive™ is a vendor-agnostic integrated solution enabling remote scanning of MR, CT, PET/CT, and Ultrasound procedures Amidst radiology technologist shortages, remote scanning in a command center configuration enables the workforce to scan at multiple locations simultaneously with a high level of expertiseRadNet has connected more than 300 MR, CT, PET/CT, and Ultrasound systems with TechLive™, delivering operational efficiency and increased access to advanced procedures LOS ANGELES and SOMERVI...

 PRESS RELEASE

RadNet, Inc. Announces Date of its Second Quarter 2025 Financial Resul...

RadNet, Inc. Announces Date of its Second Quarter 2025 Financial Results Conference Call LOS ANGELES, July 25, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers and digital health solutions, announced today that it will host a conference call to discuss its second quarter 2025 financial results on Monday, August 11, 2025 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time). Investors are invited to listen to RadNet’s conference ca...

 PRESS RELEASE

RadNet’s Wholly-Owned Subsidiary, DeepHealth, Completes Acquisition of...

RadNet’s Wholly-Owned Subsidiary, DeepHealth, Completes Acquisition of iCAD Acquisition contributes iCAD's commercial, technology, and regulatory capabilitiesThe acquisition positions DeepHealth with an industry-leading suite of AI-powered breast cancer image interpretation and workflow solutionsThe combination is expected to provide acceleration of AI adoption and expanded worldwide access to advanced breast cancer screening and diagnosis technologies LOS ANGELES, July 17, 2025 (GLOBE NEWSWIRE) --  RadNet, Inc. (NASDAQ: RDNT) (“RadNet”), a national leader in providing high-quality...

 PRESS RELEASE

Regal Medical Group, Lakeside Community Healthcare and ADOC Medical Gr...

Regal Medical Group, Lakeside Community Healthcare and ADOC Medical Group Add RadNet’s AI-Powered Enhanced Breast Cancer Detection (EBCD) Program to its Membership Benefits in Southern California Program will increase access to cutting-edge AI-powered breast cancer detection and is designed to boost compliance with annual cancer-screening guidelinesRegal Medical Group, Lakeside Community Healthcare and ADOC Medical Group are affiliates of one of Southern California’s largest health networks, which manages nearly 600,000 members from newborns to Medicare recipientsRegal Medical Group, Lakesi...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch